SORCS2 and Alzheimer disease: However, an increased Aβ burden as well as additional phenotypes, such as elevated levels of GFAP and IL-33, and induced cell death, shared by PDAPP mice with global and astrocyte-specific Sorcs2 gene defect, argue that astrocytic SORCS2 deficiency plays a decisive role in AD pathology.